Status:
TERMINATED
Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy
Lead Sponsor:
Columbia University
Conditions:
Cerebral Palsy
Eligibility:
All Genders
12-65 years
Phase:
PHASE4
Brief Summary
Cerebral palsy (CP) is a common childhood-onset disability associated with motor and cognitive impairments, however most research is focused on motor outcomes. The aim of this study is to determine th...
Detailed Description
CP is a heterogeneous condition due to injury to the developing brain. It is a condition that is often marked by both cognitive and motor disorders as well as increased prevalence of depression and an...
Eligibility Criteria
Inclusion
- Diagnosed with Cerebral Palsy
Exclusion
- Currently pregnant
- Unstable seizure condition
- Currently taking methadone
- Currently taking other dopamine agonists
- Currently taking anti-psychotic medication
- Previously taken amantadine
- Diagnosed with Chronic Kidney Disease (CKD)
Key Trial Info
Start Date :
February 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2022
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04273737
Start Date
February 28 2020
End Date
February 22 2022
Last Update
May 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University Irving Medical Center
New York, New York, United States, 10032